Sodium-Glucose cotransporter-2 inhibitors for treatment of nonalcoholic fatty liver disease: a meta-analysis of randomized controlled trials - Mantovani, A; Petracca, G; Csermely, A; Beatrice, G; Targher, G (Metabolites, 2020)